EMPATHY: Evaluation of 'Melody' Paracentesis Device for Ascites Therapy

Sponsor
University of Nottingham (Other)
Overall Status
Completed
CT.gov ID
NCT03191851
Collaborator
Mediplus Ltd UK (Other), Enteric healthcare technology Co-operative (Other)
101
1
3
36.2
2.8

Study Details

Study Description

Brief Summary

Ascites is the accumulation of fluid inside the abdomen. This can happen when the liver fails due to a substantial amount of scarring (cirrhosis). Patients (pts) must have this fluid drained and as cirrhosis progresses, patients will require drainage of ascites repeatedly on a regular basis, leading to frequent hospitals visits and increased complications.

The current drainage device is slow and doesn't always drain completely so pts have to return repeatedly to keep symptoms under control.

A new device (called Melody) has been developed and specifically designed for the purpose of draining ascites fluid, which the Investigators expect to drain faster and completely.

This study will compare the volume of ascites drained using the new 'Melody' catheter device with that used in standard NHS practice. If the melody catheter device is confirmed as superior to the current device this would improve patient experience (less frequent visits to hospital and increased length of time between visits).

With fewer procedures performed per patient, the pressure on the NHS would be greatly reduced in terms of time and costs.

Condition or Disease Intervention/Treatment Phase
  • Device: standard device
  • Device: Melody Device
  • Device: Melody Device with Pump
N/A

Detailed Description

Large volume paracentesis has been established as a treatment for symptomatic ascites and is performed regularly in secondary care hospitals widely across the UK.

Lack of a device specifically designed to perform paracentesis means that flow of ascites fluid through the catheter is not optimal leading to incomplete drainage and hence, frequent repeated paracentesis as well as a number of complications.

A new 'Melody' catheter device has been designed and developed in collaboration with Mediplus Ltd and NIHR Enteric Bowel function Healthcare Technology Co-operative; specifically designed to improve the performance characteristics of paracentesis procedure.

(The 'Melody ascites drainage catheter' including 'sterile ascetic drainage sets' is CE marked for clinical use). In addition, investigators would also like to confirm whether the addition of a pump will improve drainage with this device further.

The Investigators propose to carry out a feasibility study, 'EMPATHY', with an aim to compare the performance characteristics of 'Melody' catheter device (with and without addition of 'Andromeda' pump) with the current device. 112 patients with ascites requiring therapeutic paracentesis will be randomised to undergo the procedure using one of the two devices. The volume of ascites drained per session will be compared along with ease of insertion and removal as well as patient experience including all adverse events up to 7 days following the procedure. The outcomes of this feasibility study will inform further refinement of the 'Melody' catheter device as well as a future large multi-centre randomised controlled trial evaluating the cost-effectiveness of the new 'Melody' catheter device in therapeutic paracentesis

Study Design

Study Type:
Interventional
Actual Enrollment :
101 participants
Allocation:
Randomized
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Evaluation of 'Melody' Paracentesis Device for Ascites Therapy in Patients With Cirrhosis (EMPATHY)
Actual Study Start Date :
Jan 4, 2016
Actual Primary Completion Date :
Jan 10, 2019
Actual Study Completion Date :
Jan 10, 2019

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Standard Device

Standard device

Device: standard device
paracentesis using standard

Experimental: Melody Device

Melody device without Pump

Device: Melody Device
paracentesis using Melody Device
Other Names:
  • Melody Catheter
  • Experimental: Melody Device with pump

    Melody Catheter device with Andromeda Pump

    Device: Melody Device with Pump
    paracentesis using Melody Device with Pump
    Other Names:
  • Melody Catheter with Andromeda Pump
  • Outcome Measures

    Primary Outcome Measures

    1. Amount of ascites fluid drained (litres) [Up to 6 hours]

      Amount of ascites fluid drained in one session (litres)

    Secondary Outcome Measures

    1. Adverse Events [Up to 7 days]

      As reported by patients using a visual analogue scale

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 80 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Ascites due to cirrhosis of the liver.

    • Aged 18-80 years.

    • Ability to give written consent.

    Exclusion Criteria:
    • Known untreated spontaneous bacterial peritonitis.

    • Disseminated intravascular coagulation at the time of consenting.

    • Pregnancy.

    • Patients who have had more than six ascitic drainage procedures.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Queen Day Case Unit Nottingham University Hospitals NHS Trust Nottingham United Kingdom NG7 2UH

    Sponsors and Collaborators

    • University of Nottingham
    • Mediplus Ltd UK
    • Enteric healthcare technology Co-operative

    Investigators

    • Principal Investigator: Guruprasad Aithal, NIHR Nottingham Biomedical Research Centre, Nottingham University Hospitals NHS Trust & University of Nottingham

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    University of Nottingham
    ClinicalTrials.gov Identifier:
    NCT03191851
    Other Study ID Numbers:
    • 14083
    First Posted:
    Jun 19, 2017
    Last Update Posted:
    Nov 19, 2020
    Last Verified:
    Nov 1, 2020
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Nov 19, 2020